Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 42,579 | 36,119 | -535,977 | -581,632 | -540,695 |
| Depreciation Amortization | -5,396 | -3,657 | -1,779 | 178 | 1,852 |
| Accounts receivable | 40,330 | 21,521 | -185,699 | -104,227 | -22,180 |
| Other Working Capital | -374,989 | -329,611 | -481,089 | -330,799 | -176,087 |
| Other Operating Activity | 70,342 | 33,552 | 703,551 | 570,144 | 405,480 |
| Operating Cash Flow | $-227,134 | $-242,076 | $-500,993 | $-446,336 | $-331,630 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 191,879 | 261,240 | N/A | -135,139 | 34,659 |
| PPE Investments | -61,611 | -32,444 | -76,106 | -57,067 | -27,394 |
| Purchase Of Investment | N/A | N/A | -2,048,940 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 1,868,482 | N/A | N/A |
| Purchase Sale Intangibles | -10,000 | -10,000 | 90,761 | 90,761 | 101,861 |
| Other Investing Activity | -10,000 | -10,000 | 90,761 | 90,761 | 101,861 |
| Investing Cash Flow | $120,268 | $218,796 | $-165,803 | $-101,445 | $109,126 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 62,058 | 22,140 | 51,246 | 49,303 | 33,898 |
| Other Financing Activity | 0 | 0 | 73,758 | 73,758 | 73,758 |
| Financing Cash Flow | $62,058 | $22,140 | $125,004 | $123,061 | $107,656 |
| Beginning Cash Position | 444,009 | 444,009 | 985,801 | 985,801 | 985,801 |
| End Cash Position | 399,201 | 442,869 | 444,009 | 561,081 | 870,953 |
| Net Cash Flow | $-44,808 | $-1,140 | $-541,792 | $-424,720 | $-114,848 |
| Free Cash Flow | |||||
| Operating Cash Flow | -227,134 | -242,076 | -500,993 | -446,336 | -331,630 |
| Capital Expenditure | -61,611 | -32,444 | -76,106 | -57,067 | -27,394 |
| Free Cash Flow | -288,745 | -274,520 | -577,099 | -503,403 | -359,024 |